Zandu Pharmaceuticals manufactures pharmaceutical preparations. The company specialises in ayurvedic products such as Ghritas, Churna and medicinal oils. The products of the company are sold under the brand name 'Zandu'.
Omaxe Ltd. is a real estate development and construction company with operations in 30 cities across 9 states in India. Omaxe is involved in residential and commercial real estate development projects ranging from integrated townships, group housing,... More
ZANDU REALTY | OMAXE | ZANDU REALTY/ OMAXE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 24.2 | 26.2 | 92.5% | View Chart |
P/BV | x | 0.7 | 0.8 | 95.3% | View Chart |
Dividend Yield | % | 0.0 | 1.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ZANDU REALTY Mar-14 |
OMAXE Mar-19 |
ZANDU REALTY/ OMAXE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,269 | 229 | 554.4% | |
Low | Rs | 789 | 202 | 391.2% | |
Sales per share (Unadj.) | Rs | 358.5 | 63.8 | 562.1% | |
Earnings per share (Unadj.) | Rs | 474.4 | 2.7 | 17,836.8% | |
Cash flow per share (Unadj.) | Rs | 474.4 | 3.2 | 15,054.8% | |
Dividends per share (Unadj.) | Rs | 0 | 0.70 | 0.0% | |
Dividend yield (eoy) | % | 0 | 0.3 | 0.0% | |
Book value per share (Unadj.) | Rs | 2,630.2 | 95.2 | 2,764.1% | |
Shares outstanding (eoy) | m | 0.81 | 182.90 | 0.4% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 2.9 | 3.4 | 85.0% | |
Avg P/E ratio | x | 2.2 | 80.9 | 2.7% | |
P/CF ratio (eoy) | x | 2.2 | 68.3 | 3.2% | |
Price / Book Value ratio | x | 0.4 | 2.3 | 17.3% | |
Dividend payout | % | 0 | 26.3 | 0.0% | |
Avg Mkt Cap | Rs m | 833 | 39,378 | 2.1% | |
No. of employees | `000 | NA | 1.1 | 0.0% | |
Total wages/salary | Rs m | 0 | 666 | 0.0% | |
Avg. sales/employee | Rs Th | NM | 11,067.5 | - | |
Avg. wages/employee | Rs Th | NM | 631.8 | - | |
Avg. net profit/employee | Rs Th | NM | 461.6 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 290 | 11,665 | 2.5% | |
Other income | Rs m | 274 | 337 | 81.4% | |
Total revenues | Rs m | 565 | 12,002 | 4.7% | |
Gross profit | Rs m | 225 | 1,281 | 17.5% | |
Depreciation | Rs m | 0 | 90 | 0.0% | |
Interest | Rs m | 3 | 743 | 0.5% | |
Profit before tax | Rs m | 496 | 786 | 63.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 111 | 299 | 37.2% | |
Profit after tax | Rs m | 384 | 487 | 79.0% | |
Gross profit margin | % | 77.3 | 11.0 | 703.8% | |
Effective tax rate | % | 22.4 | 38.1 | 58.9% | |
Net profit margin | % | 132.3 | 4.2 | 3,173.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,439 | 96,201 | 1.5% | |
Current liabilities | Rs m | 560 | 76,770 | 0.7% | |
Net working cap to sales | % | 302.5 | 166.6 | 181.6% | |
Current ratio | x | 2.6 | 1.3 | 204.9% | |
Inventory Days | Days | 1,310 | 2,632 | 49.8% | |
Debtors Days | Days | 0 | 110 | 0.0% | |
Net fixed assets | Rs m | 0 | 5,986 | 0.0% | |
Share capital | Rs m | 81 | 1,829 | 4.4% | |
"Free" reserves | Rs m | 1,032 | 15,575 | 6.6% | |
Net worth | Rs m | 2,131 | 17,404 | 12.2% | |
Long term debt | Rs m | 0 | 11,536 | 0.0% | |
Total assets | Rs m | 2,691 | 107,601 | 2.5% | |
Interest coverage | x | 146.7 | 2.1 | 7,132.8% | |
Debt to equity ratio | x | 0 | 0.7 | 0.0% | |
Sales to assets ratio | x | 0.1 | 0.1 | 99.5% | |
Return on assets | % | 14.4 | 1.1 | 1,260.8% | |
Return on equity | % | 18.0 | 2.8 | 645.3% | |
Return on capital | % | 23.4 | 5.3 | 443.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 656 | 4,005 | 16.4% | |
From Investments | Rs m | -627 | 164 | -382.2% | |
From Financial Activity | Rs m | NA | -4,350 | 0.0% | |
Net Cashflow | Rs m | 29 | -181 | -16.0% |
Indian Promoters | % | 35.5 | 75.0 | 47.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.3 | 2.4 | 12.4% | |
FIIs | % | 0.0 | 11.1 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 64.2 | 11.5 | 558.3% | |
Shareholders | 27,223 | 75,160 | 36.2% | ||
Pledged promoter(s) holding | % | 0.0 | 75.5 | - |
Compare ZANDU REALTY With: POKARNA MADHUCON PROJECTS REL.INDUS.INFRAS HUBTOWN UNITECH
Indian share markets witnessed huge selling during closing hours today and ended their day lower.
Should you apply for the IPO of Mindspace Business Parks REIT?
For the quarter ended December 2019, OMAXE LTD has posted a net profit of Rs 63 m (down 26.4% YoY). Sales on the other hand came in at Rs 2 bn (down 31.0% YoY). Read on for a complete analysis of OMAXE LTD's quarterly results.
Here's an analysis of the annual report of OMAXE LTD for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of OMAXE LTD. Also includes updates on the valuation of OMAXE LTD.
For the quarter ended June 2019, OMAXE LTD has posted a net profit of Rs 149 m (up 72.4% YoY). Sales on the other hand came in at Rs 4 bn (up 103.5% YoY). Read on for a complete analysis of OMAXE LTD's quarterly results.
For the quarter ended March 2019, OMAXE LTD has posted a net profit of Rs 208 m (up 0.5% YoY). Sales on the other hand came in at Rs 3 bn (down 39.0% YoY). Read on for a complete analysis of OMAXE LTD's quarterly results.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
An Indian company founded three decades ago in a garage caught my attention...
In this video, I'll show you how to allocate your capital as a day trader.
More